Skip to content
★ Sign in to follow
WJ

William J. Newell

Executive
Chairman & CEO
Total declarations
23
Companies
2
▲ Purchases (2 ops.)
€534k
▼ Sales (0 ops.)
—

Latest filing published 07 Mar 2025 for Sutro Biopharma, INC..

Filing timeline

BuySale
William J. Newell

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 15 Mar 2022 · 1700 days ago · €71k
    -38.4%
    Entry US$85.00 · Close at T+365 US$52.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

William J. Newell: trading record in brief

This profile gathers the share dealings of William J. Newell across 2 companies, led by Sutro Biopharma, Inc. and Vaxcyte, Inc. Between 1 October 2018 and 5 March 2025, the trades on record add up to 23 filings.

On the market, this insider has only ever bought: 2 purchases, €534k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants and 13 option exercises.

The record was last updated on 7 March 2025 with an option exercise in Sutro Biopharma, Inc. The last insider purchase was made public on 15 March 2022, 1,700 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to William J. Newell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations